COLIGO, a novel alternative to antibiotics to protect piglets against diarrhoea

COLIGO interferes with the attachment of F18+ E coli to the pig’s intestinal epithelium.  In vivo results demonstrate it significantly reduces duration of shedding and the quantity of F18+ E coli bacteria that are colonising the intestine and being shed in the environment.

You can find some proof of concept data on the efficacy of COLIGO in the Technology Offer and if you are interested we can provide you with all the publications in the reference list.

We offer a license to develop and market COLIGO and we are open to assist during the transfer of the technology and the development phase.

Please download the Technology Offer on COLIGO for more information.

TO COLIGO non-confidential